161 related articles for article (PubMed ID: 31426124)
1. Special delivery: Engineered endothelial cells for pulmonary arterial hypertension.
Chambers DC
Respirology; 2019 Nov; 24(11):1042-1043. PubMed ID: 31426124
[No Abstract] [Full Text] [Related]
2. [Pulmonary arterial hypertension, bone marrow, endothelial cell precursors and serotonin].
Ayme-Dietrich E; Banas SM; Monassier L; Maroteaux L
Biol Aujourdhui; 2016; 210(2):79-88. PubMed ID: 27687599
[TBL] [Abstract][Full Text] [Related]
3. Letter by Nadeau et al Regarding Article, "Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension".
Nadeau V; Bonnet S; Paulin R
Circulation; 2019 Aug; 140(7):e286-e287. PubMed ID: 31403848
[No Abstract] [Full Text] [Related]
4. Targeting BMPR2 Trafficking with Chaperones: An Important Step toward Precision Medicine in Pulmonary Arterial Hypertension.
Andruska A; Ali MK; Spiekerkoetter E
Am J Respir Cell Mol Biol; 2020 Aug; 63(2):137-138. PubMed ID: 32339467
[No Abstract] [Full Text] [Related]
5. Response by Mendes-Ferreira et al to Letter Regarding Article, "Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension".
Mendes-Ferreira P; Manaud G; Perros F
Circulation; 2019 Aug; 140(7):e288-e289. PubMed ID: 31403844
[No Abstract] [Full Text] [Related]
6. Defective cellular trafficking of the bone morphogenetic protein receptor type II by mutations underlying familial pulmonary arterial hypertension.
John A; Kizhakkedath P; Al-Gazali L; Ali BR
Gene; 2015 Apr; 561(1):148-56. PubMed ID: 25688877
[TBL] [Abstract][Full Text] [Related]
7. Modulation of Endothelial Bone Morphogenetic Protein Receptor Type 2 Activity by Vascular Endothelial Growth Factor Receptor 3 in Pulmonary Arterial Hypertension.
Hwangbo C; Lee HW; Kang H; Ju H; Wiley DS; Papangeli I; Han J; Kim JD; Dunworth WP; Hu X; Lee S; El-Hely O; Sofer A; Pak B; Peterson L; Comhair S; Hwang EM; Park JY; Thomas JL; Bautch VL; Erzurum SC; Chun HJ; Jin SW
Circulation; 2017 Jun; 135(23):2288-2298. PubMed ID: 28356442
[TBL] [Abstract][Full Text] [Related]
8. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.
Teichert-Kuliszewska K; Kutryk MJ; Kuliszewski MA; Karoubi G; Courtman DW; Zucco L; Granton J; Stewart DJ
Circ Res; 2006 Feb; 98(2):209-17. PubMed ID: 16357305
[TBL] [Abstract][Full Text] [Related]
9. BMPRII influences the response of pulmonary microvascular endothelial cells to inflammatory mediators.
Vengethasamy L; Hautefort A; Tielemans B; Belge C; Perros F; Verleden S; Fadel E; Van Raemdonck D; Delcroix M; Quarck R
Pflugers Arch; 2016 Nov; 468(11-12):1969-1983. PubMed ID: 27816994
[TBL] [Abstract][Full Text] [Related]
10. RNA Sequencing Analysis Detection of a Novel Pathway of Endothelial Dysfunction in Pulmonary Arterial Hypertension.
Rhodes CJ; Im H; Cao A; Hennigs JK; Wang L; Sa S; Chen PI; Nickel NP; Miyagawa K; Hopper RK; Tojais NF; Li CG; Gu M; Spiekerkoetter E; Xian Z; Chen R; Zhao M; Kaschwich M; Del Rosario PA; Bernstein D; Zamanian RT; Wu JC; Snyder MP; Rabinovitch M
Am J Respir Crit Care Med; 2015 Aug; 192(3):356-66. PubMed ID: 26030479
[TBL] [Abstract][Full Text] [Related]
11. Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension.
Tojais NF; Cao A; Lai YJ; Wang L; Chen PI; Alcazar MAA; de Jesus Perez VA; Hopper RK; Rhodes CJ; Bill MA; Sakai LY; Rabinovitch M
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1559-1569. PubMed ID: 28619995
[TBL] [Abstract][Full Text] [Related]
12. Assessment of a pulmonary origin for blood outgrowth endothelial cells by examination of identical twins harboring a BMPR2 mutation.
Ormiston ML; Southgate L; Treacy C; Pepke-Zaba J; Trembath RC; Machado RD; Morrell NW
Am J Respir Crit Care Med; 2013 Jul; 188(2):258-60. PubMed ID: 23855704
[No Abstract] [Full Text] [Related]
13. Elafin Reverses Pulmonary Hypertension via Caveolin-1-Dependent Bone Morphogenetic Protein Signaling.
Nickel NP; Spiekerkoetter E; Gu M; Li CG; Li H; Kaschwich M; Diebold I; Hennigs JK; Kim KY; Miyagawa K; Wang L; Cao A; Sa S; Jiang X; Stockstill RW; Nicolls MR; Zamanian RT; Bland RD; Rabinovitch M
Am J Respir Crit Care Med; 2015 Jun; 191(11):1273-86. PubMed ID: 25853696
[TBL] [Abstract][Full Text] [Related]
14. Different Cytokine Patterns in BMPR2-Mutation-Positive Patients and Patients With Pulmonary Arterial Hypertension Without Mutations and Their Influence on Survival.
Schwiening M; Swietlik EM; Pandya D; Burling K; Barker P; Feng OY; Treacy CM; Abreu S; Wort SJ; Pepke-Zaba J; Graf S; Marciniak SJ; Morrell NW; Soon E
Chest; 2022 Jun; 161(6):1651-1656. PubMed ID: 35063447
[No Abstract] [Full Text] [Related]
15. PHorecasting Heritable Pulmonary Arterial Hypertension: Are We Nearly There Yet?
Aldred MA
Am J Respir Crit Care Med; 2020 Dec; 202(11):1500-1502. PubMed ID: 32835509
[No Abstract] [Full Text] [Related]
16. [Pulmonary arterial hypertension in a pedigree with bone morphogenetic protein receptor 2 c.282 mutation].
Song JR; Zhang JW; Li B; Deng MJ; Cao YS
Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Jul; 51(7):769-772. PubMed ID: 37460431
[TBL] [Abstract][Full Text] [Related]
17. Targeting bone morphogenic protein receptor 2 (BMPR2) signalling to treat pulmonary arterial hypertension.
Rubin LJ
Eur Respir J; 2017 Sep; 50(3):. PubMed ID: 28893872
[No Abstract] [Full Text] [Related]
18. BMPR2 gene delivery reduces mutation-related PAH and counteracts TGF-β-mediated pulmonary cell signalling.
Feng F; Harper RL; Reynolds PN
Respirology; 2016 Apr; 21(3):526-32. PubMed ID: 26689975
[TBL] [Abstract][Full Text] [Related]
19. New pathogenic variant of BMPR2 in pulmonary arterial hypertension.
Yang X; Kong Q; Zhao C; Cai Z; Wang M
Cardiol Young; 2019 Apr; 29(4):462-466. PubMed ID: 30957726
[TBL] [Abstract][Full Text] [Related]
20. Consequences of BMPR2 Deficiency in the Pulmonary Vasculature and Beyond: Contributions to Pulmonary Arterial Hypertension.
Andruska A; Spiekerkoetter E
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
